Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

ClinicalTrials.gov ID: NCT02612311

Public ClinicalTrials.gov record NCT02612311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 1:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 (Umbralisib) Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study evaluates the combination of ublituximab, a novel monoclonal antibody, and TGR-1202, a novel PI3K delta inhibitor compared to obinutuzumab and chlorambucil, and compared to ublituximab or TGR-1202 alone in Chronic Lymphocytic Leukemia (CLL) participants.

Study identification

NCT ID
NCT02612311
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
TG Therapeutics, Inc.
Industry
Enrollment
603 participants

Conditions and interventions

Interventions

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 19, 2015 (Actual)
Primary completion
Feb 22, 2023 (Actual)
Completion
Feb 22, 2023 (Actual)
Last update posted
Dec 13, 2024

2015 – 2023

United States locations

U.S. sites
110
U.S. states
37
U.S. cities
103
Facility City State ZIP Site status
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805 —
TG Therapeutics Investigational Trial Site Mobile Alabama 36604 —
TG Therapeutics Investigational Trial Site Chandler Arizona 85224 —
TG Therapeutics Investigational Trial Site Phoenix Arizona 85016 —
TG Therapeutics Investigational Trial Site Tucson Arizona 85711 —
TG Therapeutics Investigational Trial Site Fayetteville Arkansas 72703 —
TG Therapeutics Investigational Trial Site Concord California 94520 —
TG Therapeutics Investigational Trial Site Duarte California 91010 —
TG Therapeutics Investigational Trial Site Greenbrae California 94904 —
TG Therapeutics Investigational Trial Site Pismo Beach California 93449 —
TG Therapeutics Investigational Trial Site Pleasanton California 94588 —
TG Therapeutics Investigational Trial Site San Diego California 92120 —
TG Therapeutics Investigational Trial Site Santa Barbara California 93105 —
TG Therapeutics Investigational Trial Site Whittier California 90603 —
TG Therapeutics Investigational Trial Site Aurora Colorado 80012 —
TG Therapeutics Investigational Trial Site Denver Colorado 80218 —
TG Therapeutics Investigational Trial Site Bridgeport Connecticut 06606 —
TG Therapeutics Investigational Trial Site New Haven Connecticut 06519 —
TG Therapeutics Investigational Trial Site Stamford Connecticut 06904 —
TG Therapeutics Investigational Trial Site Newark Delaware 19713 —
TG Therapeutics Investigational Trial Site Boca Raton Florida 33486 —
TG Therapeutics Investigational Trial Site Fort Myers Florida 33916 —
TG Therapeutics Investigational Trial Site Jacksonville Florida 32204 —
TG Therapeutics Investigational Trial Site Jacksonville Florida 32256 —
TG Therapeutics Investigational Trial Site Ocala Florida 34471 —
TG Therapeutics Investigational Trial Site Pensacola Florida 32504 —
TG Therapeutics Investigational Trial Site St. Petersburg Florida 33705 —
TG Therapeutics Investigational Trial Site Tallahassee Florida 32308 —
TG Therapeutics Investigational Trial Site Tampa Florida 33612 —
TG Therapeutics Investigational Trial Site West Palm Beach Florida 33407 —
TG Therapeutics Investigational Trial Site Albany Georgia 31701 —
TG Therapeutics Investigational Trial Site Macon Georgia 31201 —
TG Therapeutics Investigational Trial Site Chicago Illinois 60612 —
TG Therapeutics Investigational Trial Site Decatur Illinois 62526 —
TG Therapeutics Investigational Trial Site Maywood Illinois 60153 —
TG Therapeutics Investigational Trial Site Niles Illinois 60714 —
TG Therapeutics Investigational Trial Site Peoria Illinois 61615 —
TG Therapeutics Investigational Trial Site Swansea Illinois — —
TG Therapeutics Investigational Trial Site Urbana Illinois 61801 —
TG Therapeutics Investigational Trial Site Fort Wayne Indiana 46804 —
TG Therapeutics Investigational Trial Site Indianapolis Indiana 46237 —
TG Therapeutics Investigational Trial Site Ames Iowa 50010 —
TG Therapeutics Investigational Trial Site Cedar Rapids Iowa 52403 —
TG Therapeutics Investigational Trial Site Kansas City Kansas 64132 —
TG Therapeutics Investigational Trial Site Westwood Kansas 66210 —
TG Therapeutics Investigational Trial Site Louisville Kentucky 40207 —
TG Therapeutics Investigational Trial Site Baltimore Maryland 21202 —
TG Therapeutics Investigational Trial Site Baltimore Maryland 21215 —
TG Therapeutics Investigational Trial Site Bethesda Maryland 20817 —
TG Therapeutics Investigational Trial Site Columbia Maryland 21044 —
TG Therapeutics Investigational Trial Site Boston Massachusetts 02111 —
TG Therapeutics Investigational Trial Site Worcester Massachusetts 01608 —
TG Therapeutics Investigational Trial Site Ann Arbor Michigan 48106 —
TG Therapeutics Investigational Trial Site Detroit Michigan 48202 —
TG Therapeutics Investigational Trial Site Jackson Michigan 49201 —
TG Therapeutics Investigational Trial Site Saint Louis Park Minnesota 55416 —
TG Therapeutics Investigational Trial Site Columbia Missouri 65212 —
TG Therapeutics Investigational Trial Site Kansas City Missouri — —
TG Therapeutics Investigational Trial Site Lincoln Nebraska 68510 —
TG Therapeutics Investigational Trial Site Las Vegas Nevada 89119 —
TG Therapeutics Investigational Trial Site Lebanon New Hampshire 03756 —
TG Therapeutics Investigational Trial Site Morristown New Jersey 07962 —
TG Therapeutics Investigational Trial Site Somerville New Jersey 00876 —
TG Therapeutics Investigational Trial Site East Setauket New York 11733 —
TG Therapeutics Investigational Trial Site Glens Falls New York 12801 —
TG Therapeutics Investigational Trial Site Syracuse New York 13210 —
TG Therapeutics Investigational Trial Site Charlotte North Carolina 28204 —
TG Therapeutics Investigational Trial Site Durham North Carolina 27710 —
TG Therapeutics Investigational Trial Site Durham North Carolina — —
TG Therapeutics Investigational Trial Site Hickory North Carolina 28602 —
TG Therapeutics Investigational Trial Site Kinston North Carolina 28501 —
TG Therapeutics Investigational Trial Site Raleigh North Carolina 27607 —
TG Therapeutics Investigational Trial Site Washington North Carolina 27889 —
TG Therapeutics Investigational Trial Site Canton Ohio 44718 —
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45236 —
TG Therapeutics Investigational Trial Site Toledo Ohio 43623 —
TG Therapeutics Investigational Trial Site Portland Oregon 97227 —
TG Therapeutics Investigational Trial Site Portland Oregon 97239 —
TG Therapeutics Investigational Trial Site Springfield Oregon 97477 —
TG Therapeutics Investigational Trial Site Camp Hill Pennsylvania 17011 —
TG Therapeutics Investigational Trial Site Danville Pennsylvania 17822 —
TG Therapeutics Investigational Trial Site Hershey Pennsylvania 17033 —
TG Therapeutics Investigational Trial Site Philadelphia Pennsylvania 19106 —
TG Therapeutics Investigational Trial Site Pittsburgh Pennsylvania 15224 —
TG Therapeutics Investigational Trial Site Pittsburgh Pennsylvania 15232 —
TG Therapeutics Investigational Trial Site Pawtucket Rhode Island 00286 —
TG Therapeutics Investigational Trial Site Greenville South Carolina 29615 —
TG Therapeutics Investigational Trial Site Sioux Falls South Dakota 57105 —
TG Therapeutics Investigational Trial Site Watertown South Dakota 57201 —
TG Therapeutics Investigational Trial Site Chattanooga Tennessee 37404 —
TG Therapeutics Investigational Trial Site Nashville Tennessee 37203 —
TG Therapeutics Investigational Trial Site Austin Texas 78705 —
TG Therapeutics Investigational Trial Site Bedford Texas 76022 —
TG Therapeutics Investigational Trial Site Fort Worth Texas 76104 —
TG Therapeutics Investigational Trial Site Houston Texas 77030 —
TG Therapeutics Investigational Trial Site San Antonio Texas 78217 —
TG Therapeutics Investigational Trial Site San Antonio Texas 78229 —
TG Therapeutics Investigational Trial Site Tyler Texas 75702 —
TG Therapeutics Investigational Trial Site Ogden Utah 84405 —
TG Therapeutics Investigational Trial Site Blacksburg Virginia 24060 —
TG Therapeutics Investigational Trial Site Charlottesville Virginia 22908 —
TG Therapeutics Investigational Trial Site Fort Belvoir Virginia 22060 —
TG Therapeutics Investigational Trial Site Olympia Washington 98502 —
TG Therapeutics Investigational Trial Site Seattle Washington 98104 —
TG Therapeutics Investigational Trial Site Seattle Washington 98109 —
TG Therapeutics Investigational Trial Site Spokane Washington 99216 —
TG Therapeutics Investigational Trial Site Vancouver Washington 98684 —
TG Therapeutics Investigational Trial Site Yakima Washington 98902 —
TG Therapeutics Investigational Trial Site Milwaukee Wisconsin 53226 —
TG Therapeutics Investigational Trial Site Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02612311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2024 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02612311 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →